Back to top

Immune Design (IMDZ) Looks Good: Stock Adds 7% in Session
August 01, 2017

Read MoreHide Full Article

Immune Design Corp. (IMDZ - Free Report) was a big mover last session, as the company saw its shares rise 7% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This continues the recent uptrend for the company as the stock is now up over 24% in the past one-month time frame.

The company has seen one negative estimate revision in the past 30 days. Also, its Zacks Consensus Estimate moved lower over the same timeframe, suggesting there may be trouble down the road. So make sure to keep an eye on this stock going forward to see if this recent move higher can last.

Immune Design currently holds a Zacks Rank #2 (Buy).

Immune Design Corp. Price

 

Another top-ranked stock in the Medical - Drugs industry is Consort Medical plc (CSRMY - Free Report) , sporting a Zacks Rank #1 (Strong Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.

Is IMDZ going up? Or down? Predict to see what others think: Up or Down

Will You Make a Fortune on the Shift to Electric Cars?                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 
Here's another stock idea to consider. Much like petroleum 150 years ago, lithium power may soon shake the world, creating millionaires and reshaping geo-politics. Soon electric vehicles (EVs) may be cheaper than gas guzzlers. Some are already reaching 265 miles on a single charge.

With battery prices plummeting and charging stations set to multiply, one company stands out as the #1 stock to buy according to Zacks research.

It's not the one you think.

See This Ticker Free >>




In-Depth Zacks Research for the Tickers Above


Normally $25 each - click below to receive one report FREE:


Immune Design Corp. (IMDZ) - free report >>

Consort Medical PLC Sponsored ADR (CSRMY) - free report >>


More from Zacks Tale of the Tape

You May Like